<DOC>
	<DOCNO>NCT01267058</DOCNO>
	<brief_summary>The aim study assess safety immunogenicity GlaxoSmithKline Biologicals ' ( formerly know SmithKline Beecham Biologicals ) combine diphtheria-tetanus-acellular pertussis vaccine healthy adult , age 18 onwards , Australia .</brief_summary>
	<brief_title>Booster Study Combined Diphtheria-tetanus-acellular Pertussis Vaccine Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>At least 18 year age time vaccination Written inform consent obtain Evidence confirm pertussis disease within previous 5 year History diphtheria tetanus vaccination within past 5 year Females must pregnant lactate They must either surgically sterilize one year postmenopausal childbearing potential , must abstinent use adequate contraceptive precaution ( one month prior booster vaccination , must agree continue precaution 2 month completion vaccination . History diphtheria tetanus disease History allergic disease likely stimulate vaccination Major congenital defect serious chronic illness History progressive neurological disease Immunosuppressive therapy Any suspect confirm immune disorder Immunoglobulin therapy administration blood product within previous three month study period Acute febrile illness ( &gt; 37.5°C , axillary oral temperature ) time plan vaccination Administration investigational non registered drug vaccine within 30 day prior start present trial Simultaneous administration vaccine foreseen study protocol , within 30 day prior start present trial Any severe serious adverse experience occur previous administration DTP vaccine i.e : immediate anaphylactic unacceptable reaction investigator 's opinion , previous dose diphtheria tetanus pertussis wholecell vaccine , i.e . : encephalopathy fever &gt; 40.5°C ( 105°F ) , rectal temperature , occur vaccination diphtheria tetanus pertussis wholecell vaccine due another identifiable cause . collapse shocklike state persistent , inconsolable cry last &gt; 3 hour seizure without fever systemic allergic neurologic reaction follow previous dose tetanus diphtheria toxoid vaccine Exclusion long term followup antibody persistence : Evidence confirm pertussis , diphtheria tetanus disease vaccination diseases since previous study visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Booster vaccination</keyword>
</DOC>